- 2019. Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. British Journal of Cancer. 545-555.
- 2017. Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients. Oncoimmunology. 1-15.
- 2018. Synthesis of targeting molecules as tracers for PET and anticancer pro-drugs: investigation of tumor drug distribution.
- 2019. Synthesis of targeting molecules : PET and therapeutics.
- 2019. Sulfasalazine analogues to overcome radioresistance in cancer.
- 2020. COVID-19 and the environment: A critical review and research agenda. 1-9.